Reaction
Perfume Sensitivity reporting signals
As of the last recalculation, Perfume Sensitivity appears in 552 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is OMALIZUMAB (PRR 213.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Omalizumab | 258 | 213.4 | 214.1 |
| Montelukast Sodium | 144 | 60.0 | 60.0 |
| Cetirizine Hydrochloride Allergy | 42 | 56.5 | 56.6 |
| Cetirizine Hydrochloride Tablets | 42 | 56.5 | 56.6 |
| Fluticasone Propionate And Salmeterol Xinafoate | 63 | 44.5 | 44.6 |
| Ciclesonide | 12 | 33.9 | 34.0 |
| Theophylline | 10 | 33.4 | 33.4 |
| Fluticasone Furoate And Vilanterol Trifenatate | 29 | 32.0 | 32.1 |
| Theophylline Anhydrous | 10 | 31.0 | 31.0 |
| Diclofenac Sodium Topical Gel, 1% | 27 | 29.9 | 29.9 |
| Diclofenac Sodium 1% | 26 | 28.8 | 28.8 |
| Diclofenac Sodium Topical | 26 | 28.7 | 28.8 |
| Cetirizine | 53 | 28.4 | 28.4 |
| Budesonide And Formoterol Fumarate Dihydrate | 58 | 25.1 | 25.1 |
| Adapalene | 5 | 1.0 | 1.0 |